In breast tamoxifen-resistant (TamR) breast cancer cells, Fu et al. observed that FOXA1 amplification rewrites the 3D chromatin structure to promote super-enhancer (SE) acquisition with FOXA1 binding sites. This evidence concerns the gene FOXA1 and breast carcinoma.